**Abstract**

**Background:** Antipsychotic drugs were developed to treat schizophrenia in adults, however they have been increasingly prescribed in children and adolescents without understanding the underlying mechanisms. The serotonin, dopamine and cannabinoid pathways are involved in antipsychotic efficacy and neurodevelopment, as well as the pathophysiology of schizophrenia. This study investigated the effects of early risperidone exposure on binding densities of serotonin 5-HT~2A~ receptors (5-HT~2A~R), 5-HT~2C~ receptors (5-HT~2C~R), dopamine D~1~ receptor (D~1~R), D~2~ receptor (D~2~R) and cannabinoids CB~1~ and CB~2~ receptors (CB~1~R and CB~2~R) in the prefrontal cortex (PFC), cingulate cortex (Cg) and nucleus accumbens (NAc) and caudate putamen (CPu) of juvenile rats.

**Methods:** Male and female Sprague Dawley rats treated orally three times per day with risperidone (0.3 mg/kg) or vehicle (control) starting from postnatal day (PD) 23 (±1 day) for 3 weeks (a period corresponding to the childhood-adolescent period in humans). Quantitative autoradiographic methods were used to detect binding density of \[^3^H\]ketanserin (for 5-HT~2A~R), \[^3^H\]mesulergine (for 5-HT~2C~R/~2A~R), \[^3^H\]SCH23390 (for D~1~R), \[^3^H\]raclopride (for D~2~R), and \[^3^H\]CP55940 (binding to CB~1~R and CB~2~R) and \[^3^H\]SR141716A (for CB~1~R).

**Results:** Risperidone decreased \[^3^H\]ketanserin binding in the PFC of female rats (p\<0.05), while it significantly attenuated the \[^3^H\]SCH23390 binding in the PFC and Cg of male rats (p\<0.05). However, risperidone had no effect on \[^3^H\]mesulergine binding in both genders. Risperidone significantly increased the \[^3^H\]CP55940 bindings in the PFC, NAc (p\<0.01), and Cg, CPu of male rats (p\<0.05), but not in female rats. Risperidone tended to increase \[^3^H\]SR141716A binding in the PFC (p=0.055), NAc (p=0.055) and significantly enhanced it in the CPu of male rats only (p\<0.05).

**Discussion:** These results suggested that early risperidone exposure affected serotonin, dopamine and cannabinoid neurotransmission differentially in male and female rats. Further studies are necessary to investigate whether risperidone treatment has differential long-term effects between males and females.
